{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:29:12Z","timestamp":1788391752037,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74838-y","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:03:20Z","timestamp":1730181800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of lipid levels, adipokines and multiple myeloma: a two-sample multivariate Mendelian randomization study"],"prefix":"10.1038","volume":"14","author":[{"given":"Yi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"74838_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/s0140-6736(21)00135-5","volume":"397","author":"N van de Donk","year":"2021","unstructured":"van de Donk, N., Pawlyn, C. & Yong, K. L. Multiple myeloma. Lancet397, 410\u2013427. https:\/\/doi.org\/10.1016\/s0140-6736(21)00135-5 (2021).","journal-title":"Lancet"},{"key":"74838_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan, A. J. et al. Diagnosis and management of multiple myeloma: A review. Jama327, 464\u2013477. https:\/\/doi.org\/10.1001\/jama.2022.0003 (2022).","journal-title":"Jama"},{"key":"74838_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and Cancer\u2013viewpoint of the IARC Working Group. N. Engl. J. Med.375, 794\u2013798. https:\/\/doi.org\/10.1056\/NEJMsr1606602 (2016).","journal-title":"N. Engl. J. Med."},{"key":"74838_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bjh.12935","volume":"166","author":"LR Teras","year":"2014","unstructured":"Teras, L. R. et al. Body size and multiple myeloma mortality: A pooled analysis of 20 prospective studies. Br. J. Haematol.166, 667\u2013676. https:\/\/doi.org\/10.1111\/bjh.12935 (2014).","journal-title":"Br. J. Haematol."},{"key":"74838_CR5","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1182\/bloodadvances.2020001502","volume":"4","author":"M Went","year":"2020","unstructured":"Went, M. et al. Search for multiple myeloma risk factors using Mendelian randomization. Blood Adv.4, 2172\u20132179. https:\/\/doi.org\/10.1182\/bloodadvances.2020001502 (2020).","journal-title":"Blood Adv."},{"key":"74838_CR6","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc3174","volume":"11","author":"MJ Khandekar","year":"2011","unstructured":"Khandekar, M. J., Cohen, P. & Spiegelman, B. M. Molecular mechanisms of cancer development in obesity. Nat. Rev. Cancer11, 886\u2013895. https:\/\/doi.org\/10.1038\/nrc3174 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"74838_CR7","doi-asserted-by":"publisher","unstructured":"Hofmann, J. N. et al. Low levels of circulating adiponectin are associated with multiple myeloma risk in overweight and obese individuals. Cancer Res.76, 1935\u20131941.. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-2406 (2016).","DOI":"10.1158\/0008-5472.Can-15-2406"},{"key":"74838_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","volume":"20","author":"M Dalamaga","year":"2009","unstructured":"Dalamaga, M. et al. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: A case-control study. Cancer Causes Control CCC20, 193\u2013199. https:\/\/doi.org\/10.1007\/s10552-008-9233-7 (2009).","journal-title":"Cancer Causes Control CCC"},{"key":"74838_CR9","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/bjc.2017.282","volume":"117","author":"L Santo","year":"2017","unstructured":"Santo, L. et al. Circulating resistin levels and risk of multiple myeloma in three prospective cohorts. Br. J. Cancer117, 1241\u20131245. https:\/\/doi.org\/10.1038\/bjc.2017.282 (2017).","journal-title":"Br. J. Cancer"},{"key":"74838_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1600-0609.2009.01311.x","volume":"83","author":"JE Reseland","year":"2009","unstructured":"Reseland, J. E. et al. Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma. Eur. J. Haematol.83, 460\u2013470. https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01311.x (2009).","journal-title":"Eur. J. Haematol."},{"key":"74838_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","volume":"16","author":"X Luo","year":"2017","unstructured":"Luo, X. et al. Emerging roles of lipid metabolism in cancer metastasis. Mol. Cancer16, 76. https:\/\/doi.org\/10.1186\/s12943-017-0646-3 (2017).","journal-title":"Mol. Cancer"},{"key":"74838_CR12","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","volume":"279","author":"CR Santos","year":"2012","unstructured":"Santos, C. R. & Schulze, A. Lipid metabolism in cancer. FEBS J.279, 2610\u20132623. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08644.x (2012).","journal-title":"FEBS J."},{"key":"74838_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin, C. A., Khera, A. V. & Kathiresan, S. Mendelian randomization. Jama318, 1925\u20131926. https:\/\/doi.org\/10.1001\/jama.2017.17219 (2017).","journal-title":"Jama"},{"key":"74838_CR14","doi-asserted-by":"publisher","unstructured":"Richmond, R. C. & Davey Smith, G. Mendelian randomization: Concepts and scope. Cold Spring Harbor Perspect. Med.12https:\/\/doi.org\/10.1101\/cshperspect.a040501 (2022).","DOI":"10.1101\/cshperspect.a040501"},{"key":"74838_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol.11, 85\u201397. https:\/\/doi.org\/10.1038\/nri2921 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"74838_CR16","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1158\/1055-9965.Epi-19-0389","volume":"28","author":"T Ugai","year":"2019","unstructured":"Ugai, T. et al. Association of BMI, smoking, and Alcohol with multiple myeloma mortality in asians: A pooled analysis of more than 800,000 participants in the Asia Cohort Consortium. CCancer Epidemiol. Biomark. Prev.28, 1861\u20131867. https:\/\/doi.org\/10.1158\/1055-9965.Epi-19-0389 (2019).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"74838_CR17","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","volume":"47","author":"A Wallin","year":"2011","unstructured":"Wallin, A. & Larsson, S. C. Body mass index and risk of multiple myeloma: A meta-analysis of prospective studies. Eur. J. Cancer47, 1606\u20131615. https:\/\/doi.org\/10.1016\/j.ejca.2011.01.020 (2011).","journal-title":"Eur. J. Cancer"},{"key":"74838_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0140-6736(08)60269-x","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. & Zwahlen, M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet371, 569\u2013578. https:\/\/doi.org\/10.1016\/s0140-6736(08)60269-x (2008).","journal-title":"Lancet"},{"key":"74838_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: The STROBE-MR statement. Jama326, 1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236 (2021).","journal-title":"Jama"},{"key":"74838_CR20","doi-asserted-by":"publisher","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife7https:\/\/doi.org\/10.7554\/eLife.34408 (2018).","DOI":"10.7554\/eLife.34408"},{"key":"74838_CR21","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet.45, 1274\u20131283. https:\/\/doi.org\/10.1038\/ng.2797 (2013).","journal-title":"Nat. Genet."},{"key":"74838_CR22","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat, M. A. et al. PhenoScanner V2: An expanded tool for searching human genotype-phenotype associations. Bioinformatics35, 4851\u20134853. https:\/\/doi.org\/10.1093\/bioinformatics\/btz469 (2019).","journal-title":"Bioinformatics"},{"key":"74838_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess, S. & Thompson, S. G. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol.40, 755\u2013764. https:\/\/doi.org\/10.1093\/ije\/dyr036 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"74838_CR24","doi-asserted-by":"publisher","unstructured":"Burgess, S. et al. Guidelines for performing mendelian randomization investigations: Update for summer 2023. Wellcome Open. Res.4https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3 (2019). 186.","DOI":"10.12688\/wellcomeopenres.15555.3"},{"key":"74838_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess, S. & Thompson, S. G. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol.32, 377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"74838_CR26","doi-asserted-by":"publisher","first-page":"844733","DOI":"10.3389\/fcvm.2022.844733","volume":"9","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Mendelian randomization study of heart failure and stroke subtypes. Front. Cardiovasc. Med.9, 844733. https:\/\/doi.org\/10.3389\/fcvm.2022.844733 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"74838_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol.44, 512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"74838_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","volume":"181","author":"S Burgess","year":"2015","unstructured":"Burgess, S. & Thompson, S. G. Multivariable Mendelian randomization: The use of pleiotropic genetic variants to estimate causal effects. Am. J. Epidemiol.181, 251\u2013260. https:\/\/doi.org\/10.1093\/aje\/kwu283 (2015).","journal-title":"Am. J. Epidemiol."},{"key":"74838_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/bmt.2014.71","volume":"49","author":"KR Carson","year":"2014","unstructured":"Carson, K. R., Bates, M. L. & Tomasson, M. H. The skinny on obesity and plasma cell myeloma: A review of the literature. Bone Marrow Transplant.49, 1009\u20131015. https:\/\/doi.org\/10.1038\/bmt.2014.71 (2014).","journal-title":"Bone Marrow Transplant."},{"key":"74838_CR30","doi-asserted-by":"publisher","unstructured":"De Pergola, G. & Silvestris, F. Obesity as a major risk factor for cancer. J. Obes.2013 291546. https:\/\/doi.org\/10.1155\/2013\/291546 (2013).","DOI":"10.1155\/2013\/291546"},{"key":"74838_CR31","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1158\/1055-9965.Epi-07-0143","volume":"16","author":"BM Birmann","year":"2007","unstructured":"Birmann, B. M., Giovannucci, E., Rosner, B., Anderson, K. C. & Colditz, G. A. Body mass index, physical activity, and risk of multiple myeloma. Cancer Epidemiol. Biomark. Prev.16, 1474\u20131478. https:\/\/doi.org\/10.1158\/1055-9965.Epi-07-0143 (2007).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"74838_CR32","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1182\/blood.2019846782","volume":"133","author":"TH Mouhieddine","year":"2019","unstructured":"Mouhieddine, T. H., Weeks, L. D. & Ghobrial, I. M. Monoclonal gammopathy of undetermined significance. Blood133, 2484\u20132494. https:\/\/doi.org\/10.1182\/blood.2019846782 (2019).","journal-title":"Blood"},{"key":"74838_CR33","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00256-016-2425-4","volume":"45","author":"J Veld","year":"2016","unstructured":"Veld, J. et al. Abdominal adipose tissue in MGUS and multiple myeloma. Skelet. Radiol.45, 1277\u20131283. https:\/\/doi.org\/10.1007\/s00256-016-2425-4 (2016).","journal-title":"Skelet. Radiol."},{"key":"74838_CR34","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med.348, 1625\u20131638. https:\/\/doi.org\/10.1056\/NEJMoa021423 (2003).","journal-title":"N. Engl. J. Med."},{"key":"74838_CR35","first-page":"575","volume":"7","author":"MM Khan","year":"2006","unstructured":"Khan, M. M. et al. Risk factors for multiple myeloma: Evidence from the Japan Collaborative Cohort (JACC) study. Asian Pac. J. Cancer Prev. APJCP7, 575\u2013581 (2006).","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"74838_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41408-022-00659-9","volume":"12","author":"G Kleinstern","year":"2022","unstructured":"Kleinstern, G. et al. Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota. Blood Cancer J.12, 67. https:\/\/doi.org\/10.1038\/s41408-022-00659-9 (2022).","journal-title":"Blood Cancer J."},{"key":"74838_CR37","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1158\/0008-5472.Can-07-0274","volume":"67","author":"P Fernberg","year":"2007","unstructured":"Fernberg, P. et al. Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: A nationwide cohort study in Sweden. Cancer Res.67, 5983\u20135986. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-0274 (2007).","journal-title":"Cancer Res."},{"key":"74838_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/aje\/kwp123","volume":"170","author":"RD Pylypchuk","year":"2009","unstructured":"Pylypchuk, R. D., Schouten, L. J., Goldbohm, R. A., Schouten, H. C. & van den Brandt, P. A. Body mass index, height, and risk of lymphatic malignancies: A prospective cohort study. Am. J. Epidemiol.170, 297\u2013307. https:\/\/doi.org\/10.1093\/aje\/kwp123 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"74838_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12307-009-0034-7","volume":"3","author":"D Zipori","year":"2010","unstructured":"Zipori, D. The hemopoietic stem cell niche versus the microenvironment of the multiple myeloma-tumor initiating cell. Cancer Microenviron.3, 15\u201328. https:\/\/doi.org\/10.1007\/s12307-009-0034-7 (2010).","journal-title":"Cancer Microenviron."},{"key":"74838_CR40","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.7150\/jca.16884","volume":"7","author":"R Divella","year":"2016","unstructured":"Divella, R., De Luca, R., Abbate, I., Naglieri, E. & Daniele, A. Obesity and cancer: The role of adipose tissue and adipo-cytokines-induced chronic inflammation. J. Cancer7, 2346\u20132359. https:\/\/doi.org\/10.7150\/jca.16884 (2016).","journal-title":"J. Cancer"},{"key":"74838_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.orcp.2018.01.005","volume":"12","author":"A Tarasiuk","year":"2018","unstructured":"Tarasiuk, A., Mosi\u0144ska, P. & Fichna, J. The mechanisms linking obesity to colon cancer: An overview. Obes. Res. Clin. Pract.12, 251\u2013259. https:\/\/doi.org\/10.1016\/j.orcp.2018.01.005 (2018).","journal-title":"Obes. Res. Clin. Pract."},{"key":"74838_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","volume":"11","author":"T Deng","year":"2016","unstructured":"Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A. & Hsueh, W. A. Obesity, inflammation, and cancer. Annu. Rev. Pathol.11, 421\u2013449. https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044359 (2016).","journal-title":"Annu. Rev. Pathol."},{"key":"74838_CR43","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.leu.2404658","volume":"21","author":"J Caers","year":"2007","unstructured":"Caers, J. et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia21, 1580\u20131584. https:\/\/doi.org\/10.1038\/sj.leu.2404658 (2007).","journal-title":"Leukemia"},{"key":"74838_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2016.06.010","volume":"380","author":"EM Bullwinkle","year":"2016","unstructured":"Bullwinkle, E. M. et al. Adipocytes contribute to the growth and progression of multiple myeloma: Unraveling obesity related differences in adipocyte signaling. Cancer Lett.380, 114\u2013121. https:\/\/doi.org\/10.1016\/j.canlet.2016.06.010 (2016).","journal-title":"Cancer Lett."},{"key":"74838_CR45","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2014.06.003","volume":"20","author":"WP Cawthorn","year":"2014","unstructured":"Cawthorn, W. P. et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metabol.20, 368\u2013375. https:\/\/doi.org\/10.1016\/j.cmet.2014.06.003 (2014).","journal-title":"Cell Metabol."},{"key":"74838_CR46","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/cphy.c170046","volume":"8","author":"H Fang","year":"2018","unstructured":"Fang, H. & Judd, R. L. Adiponectin regulation and function. Compr. Physiol.8, 1031\u20131063. https:\/\/doi.org\/10.1002\/cphy.c170046 (2018).","journal-title":"Compr. Physiol."},{"key":"74838_CR47","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/oby.21894","volume":"25","author":"JN Hofmann","year":"2017","unstructured":"Hofmann, J. N. et al. Circulating adiponectin levels differ between patients with multiple myeloma and its Precursor Disease. Obesity25, 1317\u20131320. https:\/\/doi.org\/10.1002\/oby.21894 (2017).","journal-title":"Obesity"},{"key":"74838_CR48","doi-asserted-by":"publisher","unstructured":"Nigro, E. et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed. Res. Int.2014 (658913). https:\/\/doi.org\/10.1155\/2014\/658913 (2014).","DOI":"10.1155\/2014\/658913"},{"key":"74838_CR49","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima, T., Seimiya, H. & Tsuruo, T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer100, 1369\u20131372. https:\/\/doi.org\/10.1038\/sj.bjc.6605007 (2009).","journal-title":"Br. J. Cancer"},{"key":"74838_CR50","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/leu.2014.112","volume":"28","author":"EA Medina","year":"2014","unstructured":"Medina, E. A. et al. PKA\/AMPK signaling in relation to adiponectin\u2019s antiproliferative effect on multiple myeloma cells. Leukemia28, 2080\u20132089. https:\/\/doi.org\/10.1038\/leu.2014.112 (2014).","journal-title":"Leukemia"},{"key":"74838_CR51","doi-asserted-by":"publisher","unstructured":"Lin, T. C. & Hsiao, M. Leptin and Cancer: Updated functional roles in carcinogenesis, therapeutic niches, and Developments. Int. J. Mol. Sci.22https:\/\/doi.org\/10.3390\/ijms22062870 (2021).","DOI":"10.3390\/ijms22062870"},{"key":"74838_CR52","first-page":"241","volume":"28","author":"GE Pamuk","year":"2006","unstructured":"Pamuk, G. E. et al. Leptin and resistin levels in serum of patients with hematologic malignancies: Correlation with clinical characteristics. Exp. Oncol.28, 241\u2013244 (2006).","journal-title":"Exp. Oncol."},{"key":"74838_CR53","doi-asserted-by":"publisher","unstructured":"Liu, R., Gao, D., Lv, Y., Zhai, M. & He, A. Importance of circulating adipocytokines in multiple myeloma: A systematic review and meta-analysis based on case-control studies. BMC Endocr. Disorders22https:\/\/doi.org\/10.1186\/s12902-022-00939-2 (2022).","DOI":"10.1186\/s12902-022-00939-2"},{"key":"74838_CR54","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1182\/blood-2012-06-438606","volume":"120","author":"JN Hofmann","year":"2012","unstructured":"Hofmann, J. N. et al. A prospective study of circulating adipokine levels and risk of multiple myeloma. Blood120, 4418\u20134420. https:\/\/doi.org\/10.1182\/blood-2012-06-438606 (2012).","journal-title":"Blood"},{"key":"74838_CR55","doi-asserted-by":"publisher","first-page":"86075","DOI":"10.18632\/oncotarget.13342","volume":"7","author":"W Yu","year":"2016","unstructured":"Yu, W. et al. Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy. Oncotarget7, 86075\u201386086. https:\/\/doi.org\/10.18632\/oncotarget.13342 (2016).","journal-title":"Oncotarget"},{"key":"74838_CR56","doi-asserted-by":"publisher","first-page":"34329","DOI":"10.18632\/oncotarget.6020","volume":"6","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget6, 34329\u201334341. https:\/\/doi.org\/10.18632\/oncotarget.6020 (2015).","journal-title":"Oncotarget"},{"key":"74838_CR57","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/s0006-291x(02)02841-3","volume":"300","author":"L Patel","year":"2003","unstructured":"Patel, L. et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun.300, 472\u2013476. https:\/\/doi.org\/10.1016\/s0006-291x(02)02841-3 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"74838_CR58","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3324\/haematol.2016.154062","volume":"102","author":"J Pang","year":"2017","unstructured":"Pang, J. et al. Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression. Haematologica102, 1273\u20131280. https:\/\/doi.org\/10.3324\/haematol.2016.154062 (2017).","journal-title":"Haematologica"},{"key":"74838_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","volume":"92","author":"A Tentolouris","year":"2023","unstructured":"Tentolouris, A., Ntanasis-Stathopoulos, I. & Terpos, E. Obesity and multiple myeloma: Emerging mechanisms and perspectives. Semin Cancer Biol.92, 45\u201360. https:\/\/doi.org\/10.1016\/j.semcancer.2023.04.003 (2023).","journal-title":"Semin Cancer Biol."},{"key":"74838_CR60","first-page":"778","volume":"8","author":"J Long","year":"2018","unstructured":"Long, J. et al. Lipid metabolism and carcinogenesis, cancer development. Am. J. cancer Res.8, 778\u2013791 (2018).","journal-title":"Am. J. cancer Res."},{"key":"74838_CR61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.canlet.2016.11.033","volume":"388","author":"CW Lu","year":"2017","unstructured":"Lu, C. W. et al. VLDL and LDL, but not HDL, promote breast cancer cell proliferation, metastasis and angiogenesis. Cancer Lett.388, 130\u2013138. https:\/\/doi.org\/10.1016\/j.canlet.2016.11.033 (2017).","journal-title":"Cancer Lett."},{"key":"74838_CR62","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1200\/jco.2010.31.5200","volume":"29","author":"CM Kitahara","year":"2011","unstructured":"Kitahara, C. M. et al. Total cholesterol and cancer risk in a large prospective study in Korea. J. Clin. Oncol.29, 1592\u20131598. https:\/\/doi.org\/10.1200\/jco.2010.31.5200 (2011).","journal-title":"J. Clin. Oncol."},{"key":"74838_CR63","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1503\/cmaj.081069","volume":"179","author":"EL Ding","year":"2008","unstructured":"Ding, E. L. & Hu, F. B. Cancer and cholesterol: Understanding the V-shaped association in patients with diabetes. CMAJ179, 403\u2013404. https:\/\/doi.org\/10.1503\/cmaj.081069 (2008).","journal-title":"CMAJ"},{"key":"74838_CR64","doi-asserted-by":"publisher","unstructured":"Choi, T. et al. Lipid level, lipid variability, and risk of multiple myeloma: A Nationwide Population-based study of 3,527,776 subjects. Cancers13https:\/\/doi.org\/10.3390\/cancers13030540 (2021).","DOI":"10.3390\/cancers13030540"},{"key":"74838_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-020-00963-6","volume":"13","author":"KM Pedersen","year":"2020","unstructured":"Pedersen, K. M., \u00c7olak, Y., Bojesen, S. E. & Nordestgaard, B. G. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals. J. Hematol. Oncol.13, 129. https:\/\/doi.org\/10.1186\/s13045-020-00963-6 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"74838_CR66","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/s41375-020-01081-5","volume":"35","author":"SM Jeong","year":"2021","unstructured":"Jeong, S. M. et al. Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy. Leukemia35, 1356\u20131364. https:\/\/doi.org\/10.1038\/s41375-020-01081-5 (2021).","journal-title":"Leukemia"},{"key":"74838_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00280-003-0692-y","volume":"53","author":"VT Hungria","year":"2004","unstructured":"Hungria, V. T. et al. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemother. Pharmacol.53, 51\u201360. https:\/\/doi.org\/10.1007\/s00280-003-0692-y (2004).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"74838_CR68","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1084\/jem.165.6.1761","volume":"165","author":"JD Sato","year":"1987","unstructured":"Sato, J. D., Kawamoto, T. & Okamoto, T. Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro. J. Exp. Med.165, 1761\u20131766. https:\/\/doi.org\/10.1084\/jem.165.6.1761 (1987).","journal-title":"J. Exp. Med."},{"key":"74838_CR69","first-page":"15","volume":"68","author":"JL Li","year":"1991","unstructured":"Li, J. L. et al. Cholesterol requirement for growth of IR983F and P3X63-Ag8-U1 myeloma cells in serum-free medium. Cytobios68, 15\u201322 (1991).","journal-title":"Cytobios"},{"key":"74838_CR70","first-page":"2359","volume":"74","author":"R Scolozzi","year":"1983","unstructured":"Scolozzi, R. et al. Hypocholesterolemia in multiple myeloma. Inverse relation to the component M and the clinical stage. Minerva Med.74, 2359\u20132364 (1983).","journal-title":"Minerva Med."},{"key":"74838_CR71","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0021-9258(18)33268-X","volume":"258","author":"V Quesney-Huneeus","year":"1983","unstructured":"Quesney-Huneeus, V. et al. The dual role of mevalonate in the cell cycle. J. Biol. Chem.258, 378\u2013385 (1983).","journal-title":"J. Biol. Chem."},{"key":"74838_CR72","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.freeradbiomed.2006.07.006","volume":"41","author":"A Negre-Salvayre","year":"2006","unstructured":"Negre-Salvayre, A. et al. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic. Biol. Med.41, 1031\u20131040. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2006.07.006 (2006).","journal-title":"Free Radic. Biol. Med."},{"key":"74838_CR73","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-0348-0837-8_13","volume":"816","author":"FJ Giles","year":"2014","unstructured":"Giles, F. J., Krawczyk, J., O\u2019Dwyer, M., Swords, R. & Freeman, C. The role of inflammation in leukaemia. Adv. Exp. Med. Biol.816, 335\u2013360. https:\/\/doi.org\/10.1007\/978-3-0348-0837-8_13 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"74838_CR74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1146\/annurev-nutr-071811-150709","volume":"32","author":"X Zhu","year":"2012","unstructured":"Zhu, X. & Parks, J. S. New roles of HDL in inflammation and hematopoiesis. Annu. Rev. Nutr.32, 161\u2013182. https:\/\/doi.org\/10.1146\/annurev-nutr-071811-150709 (2012).","journal-title":"Annu. Rev. Nutr."},{"key":"74838_CR75","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1126\/science.1189731","volume":"328","author":"L Yvan-Charvet","year":"2010","unstructured":"Yvan-Charvet, L. et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science328, 1689\u20131693. https:\/\/doi.org\/10.1126\/science.1189731 (2010).","journal-title":"Science"},{"key":"74838_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00277-011-1246-8","volume":"91","author":"JM Tirado-V\u00e9lez","year":"2012","unstructured":"Tirado-V\u00e9lez, J. M., Ben\u00edtez-Rond\u00e1n, A., C\u00f3zar-Castellano, I., Medina, F. & Perdomo, G. Low-density lipoprotein cholesterol suppresses apoptosis in human multiple myeloma cells. Ann. Hematol.91, 83\u201388. https:\/\/doi.org\/10.1007\/s00277-011-1246-8 (2012).","journal-title":"Ann. Hematol."},{"key":"74838_CR77","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","volume":"87","author":"I Yavasoglu","year":"2008","unstructured":"Yavasoglu, I. et al. Cholesterol levels in patients with multiple myeloma. Ann. Hematol.87, 223\u2013228. https:\/\/doi.org\/10.1007\/s00277-007-0375-6 (2008).","journal-title":"Ann. Hematol."},{"key":"74838_CR78","doi-asserted-by":"publisher","unstructured":"Liu, X. et al. Cholesterol levels provide prognostic information in patients with multiple myeloma. Clin. Lab.66https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190824 (2020).","DOI":"10.7754\/Clin.Lab.2019.190824"},{"key":"74838_CR79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fgene.2017.00117","volume":"8","author":"KE Grinde","year":"2017","unstructured":"Grinde, K. E. et al. Illustrating, quantifying, and correcting for Bias in Post-hoc Analysis of Gene-based rare variant tests of Association. Front. Genet.8, 117. https:\/\/doi.org\/10.3389\/fgene.2017.00117 (2017).","journal-title":"Front. Genet."},{"key":"74838_CR80","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1093\/rheumatology\/keaa719","volume":"60","author":"J Fan","year":"2021","unstructured":"Fan, J. et al. Causal association of adipokines with osteoarthritis: A Mendelian randomization study. Rheumatology60, 2808\u20132815. https:\/\/doi.org\/10.1093\/rheumatology\/keaa719 (2021).","journal-title":"Rheumatology"},{"key":"74838_CR81","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1053\/j.jrn.2010.01.009","volume":"20","author":"L Koz\u0142owska","year":"2010","unstructured":"Koz\u0142owska, L. et al. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy. J. Ren. Nutr.20, 255\u2013262. https:\/\/doi.org\/10.1053\/j.jrn.2010.01.009 (2010).","journal-title":"J. Ren. Nutr."},{"key":"74838_CR82","doi-asserted-by":"publisher","unstructured":"Becic, T., Studenik, C. & Hoffmann, G. Exercise increases adiponectin and reduces leptin levels in prediabetic and diabetic individuals: Systematic review and meta-analysis of randomized controlled trials. Med. Sci.6https:\/\/doi.org\/10.3390\/medsci6040097 (2018).","DOI":"10.3390\/medsci6040097"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74838-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74838-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74838-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T10:06:35Z","timestamp":1730455595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74838-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74838"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74838-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3579238\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"8 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25961"}}